Mark L. Graham

6.1k citations

53 papers · 4.5k indexed · 2 hit papers · h-index 26

Impact in

Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis

Papers in

Cancer Research 17
- Breast Cancer Treatment Studies 14
Family Practice 2

Co-authors: Lisa A. Carey Lynda Sawyer Carolyn I. Sartor Dominic T. Moore David W. Ollila Elizabeth Claire Dees Frances A. Collichio Thomas C. Spelsberg
Journals: Journal of Clinical Oncology (11 papers)Journal of Magnetic Resonance Imaging (3 papers)American Journal of Hematology (3 papers)Clinical Breast Cancer (2 papers)American Journal of Obstetrics and Gynecology (2 papers)
Partner nations: United States Canada Ireland

In The Last Decade

Mark L. Graham

52 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes 2007 · 1.6k citations

Peers

Countries citing papers authored by Mark L. Graham

Since Specialization

Citations

This map shows the geographic impact of Mark L. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Graham more than expected).

Fields of papers citing papers by Mark L. Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Graham. The network helps show where Mark L. Graham may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark L. Graham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark L. Graham Line = papers co-authored together Mark L. Graham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract GS4-01: Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor+ breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI) Cancer Research ·Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, S. T. Kimball, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Thomas E. Seay, James L. Wade, Edward C. McCarron, Soonmyung Paik, Sandra M. Swain, D. L. Wickerham, Norman Wolmark	2020	12
2	Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603) JNCI Cancer Spectrum ·Roberto A. Leon‐Ferre, Paul J. Novotny, Eric Wolfe, Stephanie S. Faubion, Kathryn J. Ruddy, Daniel Flora, Christopher Dakhil, Kendrith M. Rowland, Mark L. Graham, Nguyet Le‐Lindqwister, Thomas J. Smith, Charles L. Loprinzi	2019	52
3	Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Oncology ·Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, Jong‐Hyeon Jeong, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Thomas E. Seay, James L. Wade, Edward C. McCarron, Soonmyung Paik, Sandra M. Swain, D. Lawrence Wickerham, Norman Wolmark	2018	99
4	Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group Medical Oncology ·Ruta Rao, Melody Cobleigh, Robert J. Gray, Mark L. Graham, Larry Norton, Silvana Martino, G. Thomas Budd, James N. Ingle, William C. Wood	2010	14
5	Delivery of a Healthy Baby After First-Trimester Maternal Exposure to Lapatinib Clinical Breast Cancer ·Hanna Kelly, Mark L. Graham, Elizabeth Humes, Laneta J. Dorflinger, Kim Boggess, Bert H. O’Neil, R. Schwab, Neil L. Spector, Elizabeth Claire Dees	2006	40
6	Size of Residual Lymph Node Metastasis After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Is Prognostic Annals of Surgical Oncology ·Nancy Klauber‐DeMore, David W. Ollila, Dominic T. Moore, Chad Livasy, Benjamin F. Calvo, Han Jo Kim, Elizabeth Claire Dees, Carolyn I. Sartor, Lynda Sawyer, Mark L. Graham, Lisa A. Carey	2006	54
7	Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer Cancer Immunology Immunotherapy ·Elizabeth Claire Dees, Karen P. McKinnon, Jennifer J. Kuhns, S. J. Charitonidès, Hadrien Brochet, William Ladson, Edward J. Collins, Jeffrey A. Frelinger, 구기용, Frances A. Collichio, Lisa A. Carey, Mark E. Brecher, Mark L. Graham, H. Shelton Earp, Jonathan S. Serody	2004	29
8	Central nervous system metastases in women after multimodality therapy for high risk breast cancer Breast Cancer Research and Treatment ·Lisa A. Carey, Matthew G. Ewend, Ranjana Das, Lynda Sawyer, Elizabeth Claire Dees, Carolyn I. Sartor, Dominic T. Moore, Mark L. Graham	2004	46
9	High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer The American Journal of Surgery ·Nancy Klauber‐DeMore, Cherie M. Kuzmiak, Emma Kovak, SJ Rühle, David W. Ollila, Benjamin F. Calvo, Han Jo Kim, Anthony A. Meyer, A. Palmer, Mark L. Graham, Frances A. Collichio, Carolyn I. Sartor, Ranjana Das, Lisa A. Carey	2004	20
10	Phase II Study of Low-Dose Infusional 5-Fluorouracil and Paclitaxel (Taxol) Given Every 2 Weeks in Metastatic Breast Cancer American Journal of Clinical Oncology ·Frances A. Collichio, M. Ahinee Amamoo, Lautaro A. Duarte, Jennifer J. Griggs, Mark L. Graham	2002	6
11	Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. PubMed ·William G. Cance, Lisa A. Carey, Benjamin F. Calvo, Carolyn I. Sartor, Lynda Sawyer, Dominic T. Moore, Julian Rosenman, David W. Ollila, Mark L. Graham	2002	114
12	AnAlu-mediated 7.1 kb deletion ofBRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10 Genes Chromosomes and Cancer ·Elizabeth M. Rohlfs, Nadine Puget, Mark L. Graham, Barbara L. Weber, Judy E. Garber, 文夫中村, M. Kapella, Gilbert Lenoir, Lawrence M. Silverman, Sylvie Mazoyer	2000	60
13	Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases Journal of Magnetic Resonance Imaging ·Tara C. Noone, Richard C. Semelka, N. Cem Balci, Mark L. Graham	1999	14
14	Microangiopathic hemolytic anemia associated with metastatic breast carcinoma American Journal of Hematology ·Kenneth I. Ataga, Mark L. Graham	1999	4
15	Multiple myeloma in the breast American Journal of Hematology ·Kenneth I. Ataga, Mark L. Graham, LUCIANA DOS SANTOS NETTO DOS REYS, R Schirmer, Eugene P. Orringer	1999	4
16	Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. Journal of Clinical Oncology ·Claudine Isaacs, Nicholas J. Robert, Naila Khafwa Nur, Michael W. Schuster, Beth Overmoyer, Mark L. Graham, Bin Cai, K. Beach, John W. Loewy, James A. Kaye	1997	104
17	Liver lesion detection, characterization, and effect on patient management: Comparison of single‐phase spiral CT and current MR techniques Journal of Magnetic Resonance Imaging ·Richard C. Semelka, Suvipapun Worawattanakul, Nikolaos Kelekis, Uicc, John T. Woosley, Mark L. Graham, William G. Cance	1997	73
18	The need for epidemiologic studies of in-situ carcinoma of the breast Breast Cancer Research and Treatment ·Robert C. Millikan, Lynn G. Dressler, Joseph Geradts, Mark L. Graham	1995	29
19	Identification of Putative Nonfunctional Steroid Receptors in Breast and Endometrial Cancer Recent results in cancer research ·Douglas S. Colvard, Mark L. Graham, Nicholas J. Berg, James N. Ingle, Daniel J. Schaid, Karl C. Podratz, T. C. Spelsberg	1990	3
20	A nuclear binding assay for measurement of biologically active androgen receptors in animal tissues and human prostate cancer Journal of Steroid Biochemistry ·M. Isabel Miranda, Mark L. Graham, Nicholas J. Berg, Jinxin Cao, Thomas C. Spelsberg	1988	7

About Mark L. Graham

Mark L. Graham is a scholar working on Cancer Research, Family Practice, Oncology, Genetics and Pathology and Forensic Medicine, having authored 53 papers that have together received 4.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (17 papers), Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (8 papers), HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (7 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Cells and Metastasis (4 papers) and Breast Implant and Reconstruction (4 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.2k citations), Orthopedics and Sports Medicine (400 citations), Pathology and Forensic Medicine (741 citations) and Genetics (1.1k citations). Mark L. Graham has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Lisa A. Carey, Lynda Sawyer, Carolyn I. Sartor, Dominic T. Moore, David W. Ollila, Elizabeth Claire Dees, Frances A. Collichio, Thomas C. Spelsberg, Charles M. Perou and Nicholas J. Berg. Their work appears in journals such as Journal of Clinical Oncology, Journal of Magnetic Resonance Imaging, American Journal of Hematology, Clinical Breast Cancer and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact